13P Integrating tissue (TBx) and liquid biopsy (LBx) comprehensive genomic profiling to predict efficacy of anti-EGFR therapies in metastatic colorectal cancer (mCRC): Findings from the CAPRI-2 GOIM study
Title:
13P Integrating tissue (TBx) and liquid biopsy (LBx) comprehensive genomic profiling to predict efficacy of anti-EGFR therapies in metastatic colorectal cancer (mCRC): Findings from the CAPRI-2 GOIM study
Author:
Cioli, E. Bielo, L. Boscolo Napolitano, S. Martinelli, E. Troiani, T. Latiano, T.P. Bordonaro, R. Pisconti, S. Lotesoriere, C. Tamburini, E. Avallone, A. Lonardi, S. Iacono, D. Tagliaferri, P.S. Damonte, C. Cremolini, C. Fazio, N. Ciardiello, F. Martini, G. Ciardiello, D.